|
Monday
|
Tuesday
|
Wednesday
|
Thursday
|
Friday
|
Saturday
|
Sunday
|
|---|---|---|---|---|---|---|
1 event,
-
RIFM 2025 Information Exchange (INFOX®) Paris France Advancing Fragrance Safety Through Innovation, Science, and Collaboration Date: September 29, 2025 Location: Le Méridien Etoile, 81 Bd Gouvion-Saint-Cyr, 75017 Paris, France Come meet SenzaGen' skin sensitization experts Dr Andy Forreryd and Dr Tim Lindberg at this year's Research Institute for Fragrance Materials (RIFM) INFOX© meeting in Paris! […] |
0 events,
|
0 events,
|
1 event,
-
Understanding Biological Evaluation of Medical Devices Join the next Medicon Valley MedTech Network meeting in Lund to gain insights into the general principles of biological safety evaluation, what to consider, why it matters, and how upcoming changes to ISO 10993-1 may affect the process. SenzaGen's in vitro skin sensitization expert, Dr Andy Forreryd, will be […] |
0 events,
|
0 events,
|
0 events,
|
|
0 events,
|
0 events,
|
1 event,
-
Using GARD® to derive PoDs and safe dose levels for skin sensitizers Chemicals | Natural Extracts | Complex Mixtures Join our upcoming webinar to explore how GARD® enables the derivation of Points of Departure (PoDs) for Quantitative Risk Assessment (QRA) and helps establish safe dose levels for identified sensitizers. With broad applicability to complex mixtures […] |
0 events,
|
0 events,
|
0 events,
|
0 events,
|
|
0 events,
|
0 events,
|
1 event,
ICT 2025 / IUTOX 17th International Congress of Toxicology 📍 Beijing, China | 🗓 October 15–18, 2025 Meet us at this year's ICT/IUTOX conference in Beijing, where SenzaGen's scientific team will share new insights on quantitative skin sensitization potency assessment and present results from the pre-validation study of GARD®skin Medical Device. What to connect with […] |
1 event, |
1 event, |
1 event, |
0 events,
|
|
0 events,
|
1 event,
ASCCT 14th Annual Meeting 📍 Gaithersburg, USA | 🗓 October 21–23, 2025 Meet us at this year's ASCCT annual meeting in Gaithersburg, where SenzaGen's scientific team will share new insights on quantitative skin sensitization potency assessment and present results from the pre-validation study of GARD®skin Medical Device. What to connect with us while you are […] |
1 event, |
1 event, |
0 events,
|
0 events,
|
0 events,
|
|
0 events,
|
0 events,
|
0 events,
|
0 events,
|
0 events,
|
0 events,
|
0 events,
|
